AIA
BIO icon

Avalon Investment & Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History

Avalon Investment & Advisory’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,969
Closed -$2.56M – 334
2020
Q3 		$2.56M Sell
4,969
-6,875
-58% -$3.48M 0.06% 165
2020
Q2 		$5.35M Sell
11,844
-3,440
-23% -$1.52M 0.12% 127
2020
Q1 		$5.36M Sell
15,284
-1,138
-7% -$418K 0.14% 134
2019
Q4 		$6.08M Buy
16,422
+192
+1% +$67.7K 0.12% 138
2019
Q3 		$5.4M Sell
16,230
-210
-1% -$68.5K 0.12% 137
2019
Q2 		$5.14M Buy
16,440
+5,334
+48% +$1.6M 0.11% 144
2019
Q1 		$3.4M Buy
+11,106
New +$3M 0.08% 170

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return